USO09597335B2 (12) United States Patent (10) Patent No.: US 9,597,335 B2 Tuiten et al. (45) Date of Patent: *Mar. 21, 2017 (54) USE OF TESTOSTERONE AND A 5-HT1A 5,015,646 A 5/1991 Simms AGONST IN THE TREATMENT OF SEXUAL 5,250,534 A 10, 1993 Bell et al. 5,389,687 A 2f1995 Schaus et al. DYSFUNCTION 5,565,466 A 10, 1996 Gioco et al. 5,731,339 A 3/1998 Lowrey (71) Applicant: EMOTIONAL BRAIN B.V., Almere 5,877,216 A 3, 1999 Place et al. (NL) 6,165.975 A 12/2000 Adams et al. 6,242,436 B1 6/2001 Llewellyn 6,246,436 B1 6/2001 Lin et al. (72) Inventors: Jan Johan Adriaan Tuiten, Almere 6,251,436 B1 6/2001 Drizen et al. (NL); Johannes Martinus Maria 6,294.550 B1 9, 2001 Place et al. Bloemers, Almere (NL); Robertus 6,306,841 B1 10/2001 Place et al. Petrus Johannes De Lange, Hilversum 6,423,683 B1 7/2002 Heaton et al. (NL) 6,428,769 B1 8/2002 Rubsamen et al. 6,469,012 B1 10/2002 Ellis et al. 6,469,016 B1 10/2002 Place et al. (73) Assignee: EB IP LYBRIDOS B.V., Almere (NL) 6,472.434 B1 10/2002 Place et al. 6,541,536 B2 4/2003 Weikard et al. (*) Notice: Subject to any disclaimer, the term of this 6,593,313 B2 7/2003 Place et al. patent is extended or adjusted under 35 6,608,065 B1 8/2003 Daugan U.S.C. 154(b) by 0 days. 6,610,652 B2 8/2003 Adams et al. 6,632,419 B2 10/2003 Rubsamen et al. This patent is Subject to a terminal dis 6,964,780 B1 11/2005 King et al. claimer. 7,151,103 B2 12/2006 Borsini et al. 7,198.801 B2 4/2007 Carrara et al. 2002fOOO2973 A1 1/2002 Rubsamen et al. (21) Appl. No.: 14/960,204 2003/0022877 A1 1/2003 Dudley 2003/00278O1 A1 2/2003 McBurney (22) Filed: Dec. 4, 2015 2003/0027804 A1 2/2003 Van der Hoop 2003. O104980 A1 6/2003 Borsini et al. (65) Prior Publication Data 2003. O139384 A1 7/2003 Dudley 2004/OO 14761 A1 1/2004 Place et al. US 2016/OO82O18 A1 Mar. 24, 2016 2004/O186086 A1 9/2004 Bunschoten et al. 2004O2O8829 A1 10/2004 RubSamen et al. Related U.S. Application Data 2005/O152956 A1 7/2005 Dudley (Continued) (60) Continuation of application No. 14/049,005, filed on Oct. 8, 2013, now Pat. No. 9,211,334, which is a FOREIGN PATENT DOCUMENTS division of application No. 12/513,358, filed as application No. PCT/NL2007/050533 on Nov. 2, AU 200062635 6, 2005 2007, now Pat. No. 8,575,139. EP 2000143 12/2008 (Continued) (30) Foreign Application Priority Data OTHER PUBLICATIONS Nov. 3, 2006 (EP) ..................................... O6O76976 Amstislavskaya et al., “Effect of serotonin 5-HT1A receptor (51) Int. Cl. agonists on sexual motivation of male mice.” Bull Exp Biol Med (1999) 127(2):203-205. A6 IK3I/56 (2006.01) Angulo et al., “Vardenafil enhances clitoral and vaginal blood flow A6 IK3I/35 (2006.01) responses to pelvic nerve stimulation in female dogs.” Int J Impot A6 IK3I/568 (2006.01) Res (2003) 15(2):137-141. A6 IK 3/496 (2006.01) Ansel, “The Prescription,” in Remington's Pharmaceutical Sci A 6LX 3/59 (2006.01) ences, 17th Ed. (1985), Gennaro, (ed.), Chapter 101, pp. 1778-1787. A6 IK 45/06 (2006.01) Belikov et al., Pharmaceutical Chemistry (1993) 43-47 (machine translation provided). (52) U.S. Cl. Berman et al., “Safety and Efficacy of Sildenafil Citrate for the CPC .......... A6 IK3I/568 (2013.01); A61K 31/496 Treatment of Female Sexual Arousal Disorder: A Double-Blind, (2013.01); A61 K3I/519 (2013.01); A61 K Placebo Controlled Study,” Journal of Urology (2003) 170(6):2333 45/06 (2013.01) 2338. (58) Field of Classification Search USPC ......................................... 514/656, 657, 171 (Continued) See application file for complete search history. Primary Examiner — San-Ming Hui (74) Attorney, Agent, or Firm — Morrison & Foerster (56) References Cited LLP U.S. PATENT DOCUMENTS (57) ABSTRACT 3,976,776 A 8, 1976 Wu et al. The invention relates to the field of male and/or female 4,521,421 A 6, 1985 Foreman 4,596,795 A 6, 1986 Pitha sexual dysfunction. The invention specifically relates to the 4,640,921 A 2f1987. Othmer et al. use of testosterone and a 5-HT1A agonist. 4,833,142 A 5/1989 Hartog et al. 4,877,774 A 10, 1989 Pitha et al. 8 Claims, No Drawings US 9,597,335 B2 Page 2 (56) References Cited Haensel et al., “Flesinoxan: A Prosexual Drug for Male Rats.” European Journal of Pharmacology (1997) 330: 1-9. U.S. PATENT DOCUMENTS Holterhus et al., “Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen 2005.0245539 A1 11/2005 Mendla et al. responsive promoter constructs,” J Steroid Biochem Mol Biol 2006,004.0935 A1 2/2006 Maytornet al. (2002) 82:269-275. 2006/027O642 A1 1 1/2006 Lehman et al. International Preliminary Report on Patentability for PCT/NL2007/ 2006/0281752 A1 12/2006 Heaton et al. 2006/0287335 A1 12/2006 Sukoff RiZZO et al. 050533, mailed Jul. 2, 2009, 8 pages. 2007/0093450 A1 4/2007 Tuiten International Search Report for PCT/NL2007/050533, mailed on 2007. O1494.54 A1 6, 2007 Mattern Feb. 25, 2009, 3 pages. 2007/O154533 A1 7/2007 Dudley International Preliminary Report on Patentability for International 2009,0306026 A1 12/2009 Tuiten et al. Patent Application No. PCT/NO2007/050534, mailed Jul. 2, 2009, 2010/0093.680 A1 4/2010 Tuiten et al. 8 pages. 2010, O152145 A1 6, 2010 Tuiten et al. International Search Report for International Patent Application No. 2010, 0160270 A1 6, 2010 Tuiten et al. PCT/NO2007/050534, mailed Feb. 24, 2009, 3 pages. International Preliminary Report on Patentability for International FOREIGN PATENT DOCUMENTS Patent Application No. PCT/NO2007/050535, mailed Jul. 2, 2009, 9 pages. JP 11-504902 5, 1999 International Search Report for International Patent Application No. JP 2001-520999 11 2001 PCT/NO2007/050535, mailed Feb. 24, 2009, 3 pages. JP 2002-543,128 12/2002 International Search Report for International Patent Application No. JP 2003-530430 10, 2003 JP 2004-520320 T 2004 PCT/NL2005/000355, mailed Dec. 18, 2006, 5 pages. JP 2005-50O347 1, 2005 International Search Report for International Patent Application No. JP 2005-503374 2, 2005 PCT/NL2006/000542, mailed Jul. 17, 2007, 5 pages. NZ 524601 4/2006 Kharkevich et al., Pharmacology (3" ed. 1987) 41-42 (machine RU 2130776 5, 1999 translation provided). RU 97117167 10, 1999 Koolman et al., Biochemistry (1998) 365 (machine translation RU 2152.787 T 2000 provided). RU 2180591 3, 2002 Kuhn, "Anabolic Steroids.” Rec. Progress Hormone Research RU 2285519 10, 2006 (2002) Academic Press vol. 57, pp. 411-434. WO WO-94,28902 12/1994 Kurashina et al., “Pharmaceutical Society of Japan.” Pharmacia WO WO-95.05.188 2, 1995 (1999) 35(8):820. WO WO-95/33486 12/1995 WO WO-96,28142 9, 1996 Morali et al., (1994) “Mechanisms Regulating Male Sexual Behav WO WO-96,33705 10, 1996 ior in the Rat: Role of 3C-and 3,3-Androstanediols,” Biology of WO WO-96.036339 11, 1996 Reproduction 51:562-571. WO WO-97.003675 2, 1997 Ottani et al., “Modulatory activity of sildenafil on copulatory WO WO-99.21562 5, 1999 behavior of both intact and castrated male rats.” Pharmacology, WO WO-99.625O2 9, 1999 Biochemistry and Behavior (2002) 72:717-722. WO WO-00, 66084 11 2000 Phillips, “Female Sexual Dysfunction: Evaluation and Treatment.” WO WO-00,661.14 11 2000 Am Fam Physician (2000) 62(1): 127-136, 141-142. WO WO-O 1/78703 10, 2001 Rasia-Filho et al., “Effects of 8-OH-DPAT on Sexual Behavior of WO WO-02/26214 4/2002 Male Rats Castrated at Different Ages.” Hormones and Behavior WO WO-O2/O51420 T 2002 (1996) 30(3):251-258. WO WO-O2/O69.906 9, 2002 WO WO-037011300 2, 2003 Rendell et al., “Sildenafil for Treatment of Erectile Dysfunction in WO WO-037011301 2, 2003 Men with Diabetes a Randomized Controlled Trial,” JAMA (1999) WO WO-03/002123 9, 2003 281(5):421-426. WO WO-2004/O37173 5, 2004 Sher et al., “Vaginal Sildenafil (Viagra): A Preliminary Report of a WO WO-2004/O37262 5, 2004 Novel Method to Improve Uterine Artery Blood Flow and Endo WO WO-2005/007166 1, 2005 metrial Development in Patients Undergoing IVF,” Human Repro WO WO-2005/039530 5, 2005 duction (2000) 15(4):805-809. WO WO-2005/094827 10/2005 Shields et al., “Use of Sildenafil for Female Sexual Dysfunction.” WO WO-2005,102342 11/2005 Ann. Pharmacother. (2006) 40:931-934. WO WO-2005,107810 11/2005 Shifren et al., “Transdermal Testosterone Treatment in Women with WO WO-2006/127057 11 2006 Impaired Sexual Function after Oophorectomy,” New England WO WO-2007/0547.91 5/2007 Journal of Medicine (2000) 343:682-688. WO WO-2007/055.563 5/2007 Singh et al. (2006) “Pharmokinetics of a Testosterone Gel in Healthy Postmenopausal Women.” The Journal of Clinical Endo OTHER PUBLICATIONS crinology & Metabolism 91(1): 136-144. Sipski et al., “Sildenafil effects on sexual and cardiovascular Doggrell, “Comparison of Clinical Trials with Sildenafil. Vardenafil responses in women with spinal cord injury.” Urology (2000) and Tadalafil in Erectile Dysfunction.” Expert Opin.